Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000869377 | SCV001010799 | likely benign | Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5 | 2022-06-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501294 | SCV002804808 | likely benign | Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5; Thyrotoxic periodic paralysis, susceptibility to, 1 | 2021-12-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453796 | SCV004177760 | likely benign | Malignant hyperthermia, susceptibility to, 5 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453797 | SCV004177761 | likely benign | Thyrotoxic periodic paralysis, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003458563 | SCV004177762 | likely benign | Congenital myopathy 18 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453795 | SCV004177763 | likely benign | Hypokalemic periodic paralysis, type 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003453796 | SCV004830831 | likely benign | Malignant hyperthermia, susceptibility to, 5 | 2024-01-11 | criteria provided, single submitter | clinical testing |